| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Arlette Darfeuille-Michaud | Q16526102 |
| P2093 | author name string | Nathalie Rolhion | |
| P2860 | cites work | Helicobacter pylori outer membrane vesicles modulate proliferation and interleukin-8 production by gastric epithelial cells | Q39913016 |
| An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses | Q40198172 | ||
| The Crohn's disease-associated adherent-invasive Escherichia coli strain LF82 replicates in mature phagolysosomes within J774 macrophages. | Q40318594 | ||
| Balance of bacterial pro- and anti-inflammatory mediators dictates net effect of enteropathogenic Escherichia coli on intestinal epithelial cells | Q40345219 | ||
| Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer | Q40538834 | ||
| CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells | Q40659073 | ||
| Enteropathogenic Escherichia coli: stimulating neutrophil migration across a cultured intestinal epithelium without altering transepithelial conductance | Q40675016 | ||
| Type 1 pili-mediated adherence of Escherichia coli strain LF82 isolated from Crohn's disease is involved in bacterial invasion of intestinal epithelial cells. | Q40820619 | ||
| The comparative importance of E. coli antigen in granulomatous colitis of Boxer dogs | Q41457788 | ||
| Comparison of the invasion strategies used by Salmonella cholerae-suis, Shigella flexneri and Yersinia enterocolitica to enter cultured animal cells: endosome acidification is not required for bacterial invasion or intracellular replication | Q41516620 | ||
| Gut-associated bacterial microbiota in paediatric patients with inflammatory bowel disease. | Q42151699 | ||
| Mucosal flora in inflammatory bowel disease | Q43503928 | ||
| Adherent-invasive Escherichia coli isolated from Crohn's disease patients induce granulomas in vitro | Q43787532 | ||
| An in vitro dual model of mycobacterial granulomas to investigate the molecular interactions between mycobacteria and human host cells. | Q44997515 | ||
| High-level serum antibodies to bacterial antigens are associated with antibiotic-induced clinical remission in Crohn's disease: a pilot study | Q45074394 | ||
| Familial expression of anti-Escherichia coli outer membrane porin C in relatives of patients with Crohn's disease | Q46065836 | ||
| Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens | Q46134666 | ||
| Role of EHEC O157:H7 virulence factors in the activation of intestinal epithelial cell NF-kappaB and MAP kinase pathways and the upregulated expression of interleukin 8. | Q46809881 | ||
| Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease | Q47220054 | ||
| OmpC and the sigma(E) regulatory pathway are involved in adhesion and invasion of the Crohn's disease-associated Escherichia coli strain LF82. | Q54445085 | ||
| Molecular characterization of rectal mucosa-associated bacterial flora in inflammatory bowel disease. | Q54486654 | ||
| Regulatory and functional co-operation of flagella and type 1 pili in adhesive and invasive abilities of AIEC strain LF82 isolated from a patient with Crohn's disease. | Q54526968 | ||
| Aggregative adherence fimbriae contribute to the inflammatory response of epithelial cells infected with enteroaggregative Escherichia coli. | Q54638065 | ||
| Inflammatory Bowel Disease | Q22248115 | ||
| High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease | Q22250942 | ||
| A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease | Q22251291 | ||
| Actin filaments and the growth, movement, and spread of the intracellular bacterial parasite, Listeria monocytogenes | Q24679402 | ||
| Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine | Q24685766 | ||
| Dysbiosis in inflammatory bowel disease | Q24685931 | ||
| Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease | Q27860821 | ||
| Saccharomyces boulardii in maintenance treatment of Crohn's disease | Q28144634 | ||
| CARD4/Nod1 mediates NF-kappaB and JNK activation by invasive Shigella flexneri. | Q28344579 | ||
| Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract | Q28587612 | ||
| Pathogenic Escherichia coli | Q29616738 | ||
| Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. | Q30581062 | ||
| Strong decrease in invasive ability and outer membrane vesicle release in Crohn's disease-associated adherent-invasive Escherichia coli strain LF82 with the yfgL gene deleted | Q31154381 | ||
| Bacterial DNA within granulomas of patients with Crohn's disease--detection by laser capture microdissection and PCR. | Q33205888 | ||
| Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease | Q33256876 | ||
| Microbial factors in inflammatory bowel disease | Q33337420 | ||
| HtrA stress protein is involved in intramacrophagic replication of adherent and invasive Escherichia coli strain LF82 isolated from a patient with Crohn's disease | Q33793481 | ||
| Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial | Q33872486 | ||
| Shiga toxins induce, superinduce, and stabilize a variety of C-X-C chemokine mRNAs in intestinal epithelial cells, resulting in increased chemokine expression | Q34009265 | ||
| Shiga toxin translocation across intestinal epithelial cells is enhanced by neutrophil transmigration | Q34009274 | ||
| Pathogen-induced apoptosis of macrophages: a common end for different pathogenic strategies | Q34156265 | ||
| Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial | Q34510060 | ||
| Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's disease | Q34523071 | ||
| Flagellin of enteropathogenic Escherichia coli stimulates interleukin-8 production in T84 cells | Q34853145 | ||
| Adherent and invasive Escherichia coli is associated with granulomatous colitis in boxer dogs | Q34975747 | ||
| Host-flora interactions in inflammatory bowel disease. | Q35787630 | ||
| Purification of outer membrane vesicles from Pseudomonas aeruginosa and their activation of an IL-8 response. | Q36475891 | ||
| The bacterial weaponry: lessons from Shigella | Q36631487 | ||
| Involvement of lipoprotein NlpI in the virulence of adherent invasive Escherichia coli strain LF82 isolated from a patient with Crohn's disease | Q37427020 | ||
| Implication of mitogen-activated protein kinases in T84 cell responses to enteropathogenic Escherichia coli infection | Q39518587 | ||
| Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death | Q39521899 | ||
| Enterohemorrhagic Escherichia coli infection induces interleukin-8 production via activation of mitogen-activated protein kinases and the transcription factors NF-kappaB and AP-1 in T84 cells | Q39654974 | ||
| The Afa/Dr adhesins of diffusely adhering Escherichia coli stimulate interleukin-8 secretion, activate mitogen-activated protein kinases, and promote polymorphonuclear transepithelial migration in T84 polarized epithelial cells | Q39730178 | ||
| P433 | issue | 10 | |
| P921 | main subject | Escherichia coli | Q25419 |
| inflammatory bowel diseases | Q917447 | ||
| inflammation | Q101991 | ||
| P304 | page(s) | 1277-1283 | |
| P577 | publication date | 2007-10-01 | |
| P1433 | published in | Inflammatory Bowel Diseases | Q15749161 |
| P1476 | title | Adherent-invasive Escherichia coli in inflammatory bowel disease | |
| P478 | volume | 13 |
| Q35170024 | 17(R)-Resolvin D1 differentially regulates TLR4-mediated responses of primary human macrophages to purified LPS and live E. coli |
| Q35621970 | A breakthrough in probiotics: Clostridium butyricum regulates gut homeostasis and anti-inflammatory response in inflammatory bowel disease |
| Q46260829 | A role for bacterial urease in gut dysbiosis and Crohn's disease. |
| Q34410373 | Adherent-invasive Escherichia coli (AIEC) in pediatric Crohn's disease patients: phenotypic and genetic pathogenic features. |
| Q37777272 | An innately dangerous balancing act: intestinal homeostasis, inflammation, and colitis-associated cancer |
| Q41686526 | Analysis of Mucosa-Associated Microbiota in Colorectal Cancer |
| Q43056997 | Antimicrobial resistance impacts clinical outcome of granulomatous colitis in boxer dogs |
| Q37979685 | Association between antimicrobial resistance and virulence in Escherichia coli. |
| Q35647064 | Attenuation of Colitis by Serum-Derived Bovine Immunoglobulin/Protein Isolate in a Defined Microbiota Mouse Model |
| Q27489075 | Autophagy, Immunity, and Microbial Adaptations |
| Q33625314 | Biofilms in chronic infections - a matter of opportunity - monospecies biofilms in multispecies infections |
| Q28740558 | CEACAM6 gene variants in inflammatory bowel disease |
| Q33662142 | Characterization of housing-related spontaneous variations of gut microbiota and expression of toll-like receptors 2 and 4 in rats |
| Q37878446 | Characterization of the gastrointestinal microbiota in health and inflammatory bowel disease. |
| Q34023974 | Cigarette smoke extract (CSE) delays NOD2 expression and affects NOD2/RIPK2 interactions in intestinal epithelial cells |
| Q42164957 | Complete genome sequence of adherent invasive Escherichia coli UM146 isolated from Ileal Crohn's disease biopsy tissue |
| Q47195422 | Context-dependent Requirements for FimH and Other Canonical Virulence Factors in Gut Colonization by Extraintestinal Pathogenic Escherichia coli |
| Q35212077 | Conversion of commensal Escherichia coli K-12 to an invasive form via expression of a mutant histone-like protein |
| Q37361703 | Cross-talk between E. coli strains and a human colorectal adenocarcinoma-derived cell line |
| Q35804807 | Dextran sodium sulfate-induced inflammation alters the expression of proteins by intestinal Escherichia coli strains in a gnotobiotic mouse model |
| Q28078385 | Diarrheagenic Escherichia coli |
| Q36046182 | Differences in the Biodiversity of the Fecal Microbiota of Infants With Rotaviral Diarrhea and Healthy Infants |
| Q35069242 | Dominant fecal microbiota in newly diagnosed untreated inflammatory bowel disease patients |
| Q46256745 | Dysbiosis of the microbiome in gastric carcinogenesis |
| Q27024742 | Effector and memory T cell responses to commensal bacteria |
| Q46834406 | Effects of Lactobacillus salivarius 433118 on intestinal inflammation, immunity status and in vitro colon function in two mouse models of inflammatory bowel disease |
| Q51410420 | Effects of different rearing systems on growth, small intestinal morphology and selected indices of fermentation status in broilers. |
| Q38640999 | Effects of the Exclusive Enteral Nutrition on the Microbiota Profile of Patients with Crohn's Disease: A Systematic Review. |
| Q36477852 | Enteric Glial Cells: A New Frontier in Neurogastroenterology and Clinical Target for Inflammatory Bowel Diseases |
| Q27027602 | Enteric bacterial proteases in inflammatory bowel disease- pathophysiology and clinical implications |
| Q33870871 | Enteroaggregative Escherichia coli promotes transepithelial migration of neutrophils through a conserved 12-lipoxygenase pathway |
| Q39866886 | Enterovirulent E. coli in inflammatory and noninflammatory bowel diseases |
| Q46285689 | Fecal bacteria from treatment-naive Crohn's disease patients can skew helper T cell responses. |
| Q26865094 | Fusobacterium and Enterobacteriaceae: important players for CRC? |
| Q35541915 | Fusobacterium and Escherichia: models of colorectal cancer driven by microbiota and the utility of microbiota in colorectal cancer screening |
| Q35328976 | Fusobacterium nucleatum infection of colonic cells stimulates MUC2 mucin and tumor necrosis factor alpha |
| Q41060621 | Gene-environment interactions in inflammatory bowel disease: microbiota and genes |
| Q60930443 | Genetic diversity of Escherichia coli in gut microbiota of patients with Crohn's disease discovered using metagenomic and genomic analyses |
| Q33756129 | Genome sequence of adherent-invasive Escherichia coli and comparative genomic analysis with other E. coli pathotypes |
| Q37302559 | Host-bacteria interaction in inflammatory bowel disease |
| Q46318762 | Human genetic variation and the gut microbiome in disease |
| Q34255700 | IBD-what role do Proteobacteria play? |
| Q38971098 | IgA-coated E. coli enriched in Crohn's disease spondyloarthritis promote TH17-dependent inflammation |
| Q39254914 | Increased survival of antibiotic-resistant Escherichia coli inside macrophages |
| Q38007348 | Infection strategies of enteric pathogenic Escherichia coli |
| Q34161811 | Inflammation and vitamin D: the infection connection |
| Q26768257 | Influence of environmental factors in the development of inflammatory bowel diseases |
| Q35565733 | Influenza A virus infection of intestinal epithelial cells enhances the adhesion ability of Crohn's disease associated Escherichia coli strains |
| Q98784819 | Integrated microbiota and metabolite profiles link Crohn's disease to sulfur metabolism |
| Q42122934 | Interpretation of microbiota-based diagnostics by explaining individual classifier decisions |
| Q26781239 | Intestinal Microbiota and the Innate Immune System - A Crosstalk in Crohn's Disease Pathogenesis |
| Q27023724 | Intestinal barrier in inflammatory bowel disease |
| Q34579729 | Intestinal microbiota in inflammatory bowel disease: friend of foe? |
| Q27003192 | Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease |
| Q37780578 | LEEways: tales of EPEC, ATEC and EHEC. |
| Q42217627 | Lactoferrin differently modulates the inflammatory response in epithelial models mimicking human inflammatory and infectious diseases |
| Q64081357 | Lactoferrin in Aseptic and Septic Inflammation |
| Q38953278 | Linking the Microbiota, Chronic Disease, and the Immune System |
| Q37577712 | Making sense of the cause of Crohn's - a new look at an old disease |
| Q92154866 | Maternal Dietary Fiber Composition during Gestation Induces Changes in Offspring Antioxidative Capacity, Inflammatory Response, and Gut Microbiota in a Sow Model |
| Q35867599 | Microevolution in fimH gene of mucosa-associated Escherichia coli strains isolated from pediatric patients with inflammatory bowel disease |
| Q37886840 | Modulation of connexin signaling by bacterial pathogens and their toxins |
| Q40613666 | Molecular Signaling and Dysfunction of the Human Reactive Enteric Glial Cell Phenotype: Implications for GI Infection, IBD, POI, Neurological, Motility, and GI Disorders |
| Q39880714 | Molecular diversity of Escherichia coli in the human gut: new ecological evidence supporting the role of adherent-invasive E. coli (AIEC) in Crohn's disease |
| Q43717369 | Molecular mechanisms of Escherichia coli pathogenicity |
| Q88801234 | Molecular profiling of mucosal tissue associated microbiota in patients manifesting acute exacerbations and remission stage of ulcerative colitis |
| Q34182663 | Mouse background strain profoundly influences Paneth cell function and intestinal microbial composition |
| Q42659402 | Mucosa-associated but not luminal Escherichia coli is augmented in Crohn's disease and ulcerative colitis. |
| Q24608662 | NOD2 and ATG16L1 polymorphisms affect monocyte responses in Crohn's disease |
| Q26745706 | Novel perspectives on therapeutic modulation of the gut microbiota |
| Q38141160 | Pathogenesis of adherent-invasive Escherichia coli. |
| Q37085012 | Pathotypes and probiotics: response to a commentary on the detection of a Shiga toxin producing Escherichia coli in a Crohn's disease patient |
| Q34542111 | Phylogenetic distribution and prevalence of genes encoding class I Integrons and CTX-M-15 extended-spectrum β-lactamases in Escherichia coli isolates from healthy humans in Chandigarh, India |
| Q41213103 | Prevalence of Mycobacterium avium subsp. paratuberculosis and Escherichia coli in blood samples from patients with inflammatory bowel disease |
| Q40995492 | Preventive and therapeutic effects of Lactobacillus paracasei B21060-based synbiotic treatment on gut inflammation and barrier integrity in colitic mice |
| Q37577258 | QseC inhibition as an antivirulence approach for colitis-associated bacteria |
| Q34429054 | Recent advances in adherence and invasion of pathogenic Escherichia coli |
| Q33382536 | Reduced diversity and increased virulence-gene carriage in intestinal enterobacteria of coeliac children |
| Q33940892 | Role of meprins to protect ileal mucosa of Crohn's disease patients from colonization by adherent-invasive E. coli |
| Q33752553 | Role of the microbiota in immunity and inflammation |
| Q61812275 | Roles of Autophagy-Related Genes in the Pathogenesis of Inflammatory Bowel Disease |
| Q38990713 | Siderophore-mediated iron acquisition and modulation of host-bacterial interactions |
| Q40140858 | Specialized Pro-resolving Mediators (SPM) Rescue Infant Mice from Lethal Citrobacter rodentium Infection and Promote Immunity against Re-infection |
| Q88732443 | T Cell Proliferation and Colitis Are Initiated by Defined Intestinal Microbes |
| Q26784194 | Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases |
| Q38747897 | The Adherent/Invasive Escherichia coli Strain LF82 Invades and Persists in Human Prostate Cell Line RWPE-1, Activating a Strong Inflammatory Response |
| Q35820873 | The Vat-AIEC protease promotes crossing of the intestinal mucus layer by Crohn's disease-associated Escherichia coli. |
| Q38302847 | The human milk oligosaccharide 2'-fucosyllactose modulates CD14 expression in human enterocytes, thereby attenuating LPS-induced inflammation. |
| Q34206639 | The role of bacteria in the pathogenesis of inflammatory bowel disease |
| Q39426830 | The role of bacterial biofilms in chronic infections |
| Q33762817 | The treatment-naive microbiome in new-onset Crohn's disease |
| Q38981449 | Therapeutic modulation of gut microbiota in inflammatory bowel disease: More questions to be answered |
| Q33931575 | Transport proteins promoting Escherichia coli pathogenesis |
| Q34786166 | Understanding host-adherent-invasive Escherichia coli interaction in Crohn's disease: opening up new therapeutic strategies |
| Q39650801 | Uptake of Helicobacter pylori outer membrane vesicles by gastric epithelial cells. |
| Q52579441 | Urbanization and the gut microbiota in health and inflammatory bowel disease. |
| Q90543480 | Vitamin D Supplementation, Serum 25(OH)D Concentrations and Cardiovascular Disease Risk Factors: A Systematic Review and Meta-Analysis |
| Q94672651 | Why the discovery of adherent-invasive Escherichia coli molecular markers is so challenging? |
Search more.